StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the medical research company’s stock.
Enzo Biochem Stock Up 1.8 %
Shares of ENZ opened at $1.15 on Thursday. Enzo Biochem has a 1 year low of $0.99 and a 1 year high of $1.50. The stock has a 50 day simple moving average of $1.13 and a two-hundred day simple moving average of $1.12.
Enzo Biochem Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 34.78%. The ex-dividend date is Friday, November 15th.
Institutional Investors Weigh In On Enzo Biochem
About Enzo Biochem
Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.
Featured Articles
- Five stocks we like better than Enzo Biochem
- How to Calculate Inflation Rate
- California Resources Stock Could Be a Huge Long-Term Winner
- What Is WallStreetBets and What Stocks Are They Targeting?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.